Status:
RECRUITING
Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID
Lead Sponsor:
University of Louisville
Conditions:
Long-COVID
PASC
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is investigating the effects of using an Osteopathic Manipulative Therapy (OMT) treatment protocol that was shown to statistically improve smell in individuals suffering from Long-COVID olf...
Detailed Description
II. Description of the protocol and hypothesis with pilot data: To date, individuals suffering from Long-COVID still do not have a specific proven treatment for this disease as a whole; however, an O...
Eligibility Criteria
Inclusion
- \- Individuals must claim they have had a prior positive SARS-CoV-2 test at least 6-weeks before the consenting process to proceed with the study
- Individuals must claim they have at least one of the following symptoms greater than 6-weeks post infection that is affecting their daily life(these symptoms correlate with the SBQ™-LC):
- Symptoms of Long Covid
- Shortness of breath or Difficulty Breathing
- Difficulty with Movement (balance or tremor)
- Muscle Pain or stiffness
- Changes in sexual desire
- Worsening Generalized Pain
- Difficulty with Sleep
- Changes in Mood (anxiety or depression)
- Changes in Erectile function (Biological males only)
- Palpations (irregular heart beats)
- Altered Taste
- Changes in your Hair
- Changes in urination
- Dizziness
- Altered Smell
- Changes in Skin
- Changes in bowels
- Fatigue
- Indigestion
- Dry or irritated eyes
- Changes in sweating
- Difficulty with Cognition (memory or thinking)
- Stomach Pain
- Changes in menstruation (Biological females only)
- Chills or shivering
Exclusion
- If anyone denies they have any of the above symptoms before consent, they will be excluded from the trial
- They will also be excluded from the trial if they have suffered any fractured bones in the last 3 months (this will further decrease risk to the patient as the patient will be moved by the physician during the treatment protocol)
- Participants who are enrolled in other Long-COVID trials that have an intervention during their participation in this trial will be excluded. However, if they have a history of enrollment in a long-covid trial that has no interventions during this trial, they will not be excluded based on their history of acquiring experimental treatment.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 3 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06883513
Start Date
May 1 2025
End Date
July 3 2025
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Louisville Outpatient Care Center
Louisville, Kentucky, United States, 40202